ARCHIVES

Drug Approvals: FDA Grants Accelerated Approval to Imbruvica

This article is from The Cancer Letter archive.

Vol. 39 No. 43 | November 15, 2013

Download PDF Visit The Full Archive

Related Articles

President Accepts Rauscher Resignation

October 1, 1976

In Brief: Shingleton “Unretires” As Director Of Duke Center; O’Brien Interim Head At USC When Hammond Leave

July 24, 1981

Review Planned Of 54 Deaths In First 60 Days On Studies.

June 22, 2001

Revlimid Maintenance Therapy Delayed Progression by 90%

May 27, 2011

ACS Says New Tax Policy Hurts Charity Funds

April 25, 1980

In Brief: DOD Bill includes $135M For breast Cancer, $45M For prostate Cancer Technologies

October 3, 1997